Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CIB | RIVN |
|---|---|---|
| Price | $90.32 | $14.77 |
| Change today | ▼ 2.72% | ▼ 1.17% |
| Market cap | $21.33B | $21.38B |
| Return, 3 months | +19.3% | -14.1% |
| Return, year to date | +51.5% | -25.1% |
| Return, 1 year | +85.2% | +1.1% |
| P/E (TTM) | 15.5 | -5.7 |
| P/B | 2.4 | 4.2 |
| P/E percentile vs own 5y | 89th | 9th |
| Dividend yield | 2.99% | – |
| Revenue growth (YoY, latest qtr) | +21.9% | +27.2% |
| Net profit growth (YoY) | +52.1% | +24.9% |
| Gross margin | – | 7.5% |
| Operating margin | – | -60.1% |
| Net margin | 8.2% | -55.0% |
| Return on equity | 6.1% | -57.9% |
| Analyst target vs. price | +15.1% | +27.0% |
| Analyst buy share | 67% | 42% |
| RSI (14) | 45 | 42 |
| 30-day volatility | 28.1% | 40.9% |
| Max drawdown, 1 year | -24.0% | -42.5% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
